zika
viru
mosquitoborn
pathogen
infect
human
present
zika
viru
hijack
intracellular
transport
machineri
deliv
replic
site
track
singl
virion
reveal
follow
clathrinmedi
endocytosi
fuse
within
late
endosom
interestingli
note
two
compound
commonli
use
block
endocytosi
differ
activ
previous
anticip
bafilomycin
disabl
viral
fusion
alter
endosom
ph
complet
rewir
endosom
hub
zika
viru
zikv
ssrna
mosquitoborn
flaviviru
infect
human
although
origin
africa
hit
spotlight
almost
year
first
discoveri
due
massiv
outbreak
micronesia
south
pacif
island
south
america
estim
sinc
identif
first
case
south
america
may
total
number
human
case
contin
reach
rapid
spread
neuropatholog
complic
associ
zikv
infect
microcephali
newborn
syndrom
adult
indic
urgent
need
research
biolog
pathogen
initi
event
zikv
entri
identifi
data
regard
fate
thereaft
limit
upon
attach
permiss
cell
zikv
cross
plasma
membran
via
clathrin
endocytosi
accompani
format
tubul
depend
zikv
endocytosi
confirm
varieti
cell
model
clathrinmedi
endocytosi
cme
initi
activ
receptor
protein
follow
recruit
adaptor
complex
induc
assembl
clathrin
coat
format
membran
nich
nm
invagin
deepen
dynamin
gtpase
oligomer
around
bud
neck
cleav
cell
surfac
creat
intracellular
vesicl
first
transloc
actin
cortex
traffick
along
microtubul
vesicl
travel
across
cell
matur
first
clathrin
coat
remov
uncoat
vesicl
may
fuse
deliv
first
major
sort
station
ie
earli
endosom
vesicl
traffick
direct
small
membran
gtpase
belong
rab
famili
earli
endosom
character
presenc
earli
endosom
antigen
protein
vesicl
matur
ph
gradual
decreas
due
activ
proton
pump
fusion
acid
vesicl
earli
endosom
moder
acid
ph
cargo
sort
either
degrad
via
multivesicular
bodi
late
endosom
lysosom
recycl
cell
surfac
exosom
transgolgi
network
transport
along
degrad
pathway
associ
gradual
decreas
ph
late
endosom
lysosom
lysosom
act
storag
site
hydrolas
proteolyt
enzym
final
destin
pathway
recycl
endosom
ph
maintain
vesicl
may
target
outer
membran
via
fast
recycl
endosom
min
via
slow
recycl
endosom
min
altern
cargo
may
transport
multivesicular
bodi
intralumin
vesicl
may
recycl
cell
surfac
via
pathway
lead
releas
cargoload
exosom
nm
often
use
virus
assembl
egress
final
point
cargo
may
enter
transgolgi
network
follow
retrograd
transport
pathway
guid
microenviron
within
vesicl
travel
precis
control
virus
usual
fuse
vesicular
membran
certain
time
ie
ph
membran
composit
activ
cellular
proteas
optim
fusion
viru
depend
acid
environ
often
treat
requir
endocytosi
prior
fusion
consequ
agent
ammonium
chlorid
bafilomycin
baf
increas
intravesicular
ph
use
determin
whether
certain
virus
abl
fuse
cell
surfac
whether
endocyt
intern
requir
complement
expand
knowledg
cell
entri
intracellular
traffick
zikv
track
singl
virion
use
confoc
microscopi
separ
label
viral
capsid
envelop
protein
reveal
virion
enter
cell
via
cme
travel
late
endosom
compart
subsequ
fuse
membran
block
endosom
acidif
use
baf
inhibit
viru
cell
fusion
lead
traffick
viru
either
along
degrad
pathway
lysosom
compart
slow
recycl
cell
surfac
similar
result
expect
cell
howev
case
virion
local
cell
surfac
suggest
differ
mechan
action
surprisingli
appear
rewir
endosom
hub
alter
viru
traffick
within
endocyt
labyrinth
african
green
monkey
kidney
vero
cell
atcc
number
rrid
maintain
standard
medium
dulbeccomodifi
eagl
medium
dmem
thermofish
scientif
poland
poland
supplement
heatinactiv
fetal
bovin
serum
fb
thermofish
scientif
poland
uml
penicillin
streptomycin
immuniq
poland
addit
ciprofloxacin
zikv
strain
acquir
european
viru
archiv
propag
vero
cell
standard
medium
day
infect
viruscontain
medium
collect
titrat
control
mockinfect
vero
cell
subject
procedur
viru
mock
aliquot
store
viru
titrat
perform
confluent
vero
cell
plate
accord
method
amantadin
amtd
sigma
aldrich
poland
use
clathrinco
pit
stabil
agent
bafilomycin
butyl
baf
sigma
aldrich
poland
use
nm
vacuolar
type
hatpas
inhibitor
hamper
endosom
acidif
camostat
aminoiminomethyl
amino
benzoyl
oxi
benzeneacet
acid
dimethylamino
ester
methanesulfon
cam
sigma
aldrich
poland
use
serin
proteas
inhibitor
decanoylargvallysargchloromethylketon
cmk
sigma
aldrich
poland
use
furin
inhibitor
dynasor
acid
hydrazid
dyn
abcam
uk
use
inhibitor
gtpase
activ
dynamin
transepoxysuccinyllleucylamido
butan
n
transepoxysuccinyl
lleucin
sigma
aldrich
poland
use
cystein
proteas
inhibitor
mitmab
tetradecyltrimethylammonium
bromid
mm
abcam
uk
use
inhibitor
target
dynaminphospholipid
interact
bioshop
poland
use
mm
intracellular
alkal
agent
pitstop
n
pt
abcam
uk
use
inhibitor
ligand
associ
clathrin
amino
termin
domain
vero
cell
seed
glass
slide
cell
cultur
plate
cultur
standard
medium
two
day
upon
experiment
procedur
cell
fix
icecold
formaldehyd
pb
min
room
temperatur
wash
pb
permeabil
min
room
temperatur
afterward
nonspecif
bind
site
block
overnight
bsa
slide
incub
h
room
temperatur
primari
antizikv
antibodi
specif
envelop
protein
merck
millipor
poland
capsid
protein
kind
gift
prof
jassoy
institut
virologi
leipzig
germani
dilut
bsa
pb
visual
host
cell
protein
slide
incub
primari
antibodi
clathrin
goat
anticlathrin
hc
rrid
rabbit
rrid
rabbit
rrid
polyclon
antibodi
santa
cruz
biotechnolog
poland
rabbit
rrid
polyclon
antibodi
proteintech
uk
rabbit
monoclon
antibodi
cell
signal
technolog
poland
rabbit
polyclon
antibodi
novu
biolog
poland
rabbit
rrid
polyclon
antibodi
thermofish
scientif
poland
dilut
bsa
pb
togeth
antizikv
antibodi
next
cell
incub
anoth
h
alexa
fluor
goat
antimous
igg
rrid
thermofish
scientif
poland
alexa
fluor
rabbit
antimous
igg
rrid
thermofish
scientif
poland
dilut
bsa
pb
stain
host
cell
protein
also
alexa
fluor
goat
antirabbit
secondari
antibodi
rrid
thermofish
scientif
poland
alexa
fluor
donkey
antigoat
secondari
antibodi
rrid
thermofish
scientif
poland
dilut
ad
mix
experi
focus
sirna
silenc
inhibitor
influenc
viru
intern
cell
surfac
label
atto
thermofish
scientif
poland
dilut
pb
h
room
temperatur
nuclei
stain
dapi
rrid
thermofish
scientif
poland
dilut
pb
end
immunostain
procedur
slide
thoroughli
wash
pb
stain
slide
mount
prolong
diamond
antifad
medium
thermofish
scientif
poland
store
vero
cell
seed
mm
glass
bottom
dish
cultur
standard
medium
two
day
afterward
cell
wash
pb
incub
standard
medium
contain
nm
red
thermofish
scientif
poland
min
visual
acid
organel
next
medium
discard
cell
overlaid
control
standard
medium
observ
min
fluoresc
microscop
first
imag
min
acquir
min
upon
treatment
cell
two
mention
agent
imag
live
cell
acquir
use
evo
fl
imag
system
thermofish
scientif
poland
oil
immers
len
imag
fix
cell
taken
zeiss
lsm
version
confoc
microscop
oil
immers
len
zen
black
edit
version
imag
process
perform
imagej
fiji
rrid
nation
institut
health
bethesda
maryland
usa
coloc
paramet
pearson
mander
coeffici
calcul
use
jacop
plugin
vero
cell
seed
cell
cultur
plate
cultur
standard
medium
two
day
upon
experi
cell
fix
permeabil
block
immunostain
primari
antibodi
specif
viral
envelop
protein
merck
millipor
poland
secondari
rabbit
antimous
antibodi
label
alexa
fluor
rrid
thermofish
scientif
poland
indic
immunostain
section
proport
zikvinfect
cell
correspond
median
fluoresc
analyz
cell
popul
evalu
flow
cytometri
use
facscalibur
rrid
becton
dickinson
poland
cell
quest
softwar
rrid
becton
dickinson
poland
use
data
process
analysi
cell
seed
plate
cultur
standard
medium
two
day
afterward
cell
wash
pb
overlaid
standard
medium
supplement
inhibitor
control
incub
day
cell
viabil
examin
use
xtt
cell
viabil
assay
biolog
industri
poland
accord
manufactur
protocol
briefli
medium
discard
fresh
standard
medium
activ
xtt
solut
ad
well
h
incub
supernat
transfer
onto
new
transpar
plate
signal
formazan
deriv
tetrazolium
dye
read
nm
use
colorimet
tecan
icontrol
infinit
micropl
reader
obtain
result
normal
control
cell
viabil
set
viru
detect
quantif
perform
use
revers
transcript
rt
follow
quantit
realtim
pcr
qpcr
viral
rna
isol
cell
cultur
supernat
day
postinfect
pi
use
viral
dna
rna
kit
biotechnolog
poland
revers
transcript
carri
high
capac
cdna
revers
transcript
kit
thermofish
scientif
poland
accord
manufactur
protocol
assess
viru
yield
dna
standard
subject
qpcr
along
cdna
acquir
isol
sampl
qpcr
perform
use
kapa
probe
fast
qpcr
master
mix
kapa
biosystem
poland
zikvspecif
primer
gtc
atg
ata
ctg
ctg
att
tcc
aca
aag
tcc
cta
ttg
probe
cat
aca
gca
tca
ggt
gca
tag
label
fam
tamra
rox
use
refer
dye
signal
record
analys
use
fast
realtim
pcr
system
thermofish
scientif
poland
control
scrambl
sirna
pool
sirna
target
heavi
chain
clathrin
obtain
santa
cruz
biotechnolog
poland
sirna
specif
simian
mrna
genbank
sequenc
id
design
synthes
thermofish
scientif
poland
vero
cell
cultur
day
antibiot
serumdeplet
standard
medium
plate
transfect
appropri
sirna
use
lipofectamin
rnaimax
thermofish
scientif
poland
procedur
perform
accord
manufactur
instruct
repeat
h
later
enhanc
silenc
effect
effici
procedur
assess
western
blot
h
later
time
microscop
studi
viru
subcellular
local
cell
harvest
ripa
buffer
h
thermofish
scientif
poland
supplement
edta
proteas
inhibitor
cocktail
complet
tablet
roch
poland
protein
concentr
assess
pierc
bca
protein
assay
kit
thermofish
scientif
poland
accord
manufactur
protocol
sampl
contain
equal
amount
protein
mix
sdspage
sampl
buffer
tri
ph
sd
mgml
dtt
denatur
min
separ
sdspage
electrophoresi
subsequ
protein
electrotransf
onto
pvdf
membran
h
v
amersham
poland
nonspecif
bind
site
membran
block
h
room
temperatur
milk
bioshop
trisbuff
salin
supplement
bioshop
poland
tbst
incub
primari
antibodi
specif
clathrin
rabbit
anticlathrin
heavi
chain
polyclon
antibodi
rrid
cell
signal
technolog
poland
rabbit
polyclon
antibodi
novu
biolog
poland
dilut
clathrin
respect
bsa
tbst
overnight
addit
h
room
temperatur
primari
antibodi
specif
gapdh
rabbit
antigapdh
antibodi
rrid
cell
signal
technolog
poland
dilut
bsa
tbst
h
room
temperatur
wash
tbst
membran
incub
hrplabel
antirabbit
igg
antibodi
rrid
sigma
aldrich
poland
dilut
bsa
tbst
h
room
temperatur
final
protein
visual
chemiluminesc
use
ecl
system
amersham
poland
vero
cell
seed
standard
medium
glass
slide
plate
day
h
prior
infect
cell
cultur
medium
replac
serumdeplet
standard
medium
next
cell
cool
overlaid
nondilut
zikv
stock
rang
approxim
correspond
moi
pfuml
incub
min
synchron
cargo
particl
entri
cell
surfac
subsequ
incub
exact
time
indic
experi
cell
fix
permeabil
block
immunostain
viral
cellular
protein
indic
immunostain
section
visual
viru
subcellular
local
experi
agent
interf
viru
traffick
vero
cell
cultur
standard
medium
glass
slide
plate
day
pretreat
particular
inhibitor
h
prior
infect
afterward
cell
cool
overlaid
nondilut
zikv
stock
rang
approxim
correspond
moi
pfuml
presenc
inhibitori
agent
incub
anoth
min
synchron
cargo
intern
subsequ
virusoverlaid
cell
warm
indic
experi
time
point
cell
wash
pb
fix
permeabil
block
immunostain
viral
actin
cytoskeleton
protein
indic
immunostain
section
ident
procedur
carri
visual
viru
particl
cell
deplet
certain
protein
sirna
test
influenc
compound
viru
adhes
vero
cell
cultur
standard
medium
plate
day
cool
overlaid
icecold
nondilut
zikv
stock
rang
approxim
correspond
moi
pfuml
incub
anoth
h
cell
rins
twice
icecold
pb
cell
fix
permeabil
block
immunostain
analyz
flow
cytometri
describ
flow
cytometri
section
assess
inhibitor
influenc
viral
replic
vero
cell
cultur
standard
medium
plate
day
pretreat
select
agent
h
prior
infect
viru
approxim
correspond
moi
pfuml
overlaid
cell
presenc
inhibitor
sampl
incub
h
well
wash
thrice
pb
incub
standard
medium
supplement
inhibitor
day
pi
cultur
supernat
collect
viral
rna
isol
yield
quantifi
rtqpcr
whether
procedur
modifi
describ
result
section
experi
perform
least
twice
triplic
chart
bar
repres
mean
sd
signific
differ
compar
group
determin
singlefactor
analysi
varianc
anova
p
valu
consid
signific
first
ask
whether
zikv
enter
vero
cell
via
cme
report
vitro
system
examin
coloc
virion
cellular
protein
clathrin
caveolin
endophilin
sever
time
point
postinfect
pi
coloc
zikv
clathrin
observ
min
pi
coincid
coloc
viru
earli
endosom
marker
fig
coloc
caveolin
endophilin
observ
data
shown
coloc
rate
high
pearson
coeffici
rang
mander
coeffici
carri
complementari
studi
valid
result
subcellular
local
zikv
vero
cell
clathrin
express
transient
silenc
examin
model
virion
retain
surfac
clathrindeplet
cell
even
min
pi
contrast
control
cell
show
normal
express
clathrin
permiss
zikv
entri
fig
prove
clathrindepend
endocytosi
main
rout
zikv
intern
vero
cell
examin
effect
cme
inhibitor
viru
replic
select
compound
target
multipl
step
vesicl
format
process
includ
pitstop
pt
inhibit
associ
ligand
termin
domain
clathrin
amantadin
amtd
stabil
clathrinco
pit
mitmab
mm
target
dynaminphospholipid
interact
dynasor
dyn
inhibit
gtpase
activ
dynamin
therefor
impair
loss
load
vesicl
cell
surfac
assess
impact
inhibitor
zikv
infect
measur
viral
yield
releas
infect
cell
medium
day
pi
compound
reduc
zikv
yield
significantli
fig
suggest
zikv
enter
vero
cell
via
clathrindepend
rout
report
human
cell
endosom
hub
zikv
plethora
pathway
reach
site
fusion
host
cell
membran
condit
within
endosom
compart
differ
respect
lipidprotein
content
ph
find
viru
traffick
reach
site
fusion
use
confoc
microscopi
track
two
zikv
structur
protein
capsid
protein
viru
core
membranebound
envelop
protein
coloc
viral
protein
cellular
protein
late
endosom
slow
recycl
endosom
lysosom
analyz
min
pi
full
set
imag
avail
addit
file
figur
addit
file
figur
evid
coloc
zikv
capsid
found
peak
min
pi
fig
howev
envelop
protein
show
increas
coloc
structur
min
pi
fig
suggest
slowli
recycl
endosom
may
carri
viral
protein
cell
surfac
upon
deliveri
rna
cytoplasm
late
endosom
final
coloc
found
addit
file
figur
addit
file
figur
upon
identif
fusion
site
next
identifi
host
factor
take
part
process
viru
escap
endosom
compart
usual
occur
upon
activ
viral
fusion
protein
may
trigger
environment
condit
orand
host
proteas
therefor
examin
import
differ
host
cell
proteas
vero
cell
treat
either
furin
inhibitor
decanoylargvallysargchloromethylketon
cmk
serin
proteas
inhibitor
camostat
cam
cystein
proteas
inhibitor
four
differ
condit
h
prior
infect
h
prior
infect
h
infect
h
prior
infect
h
pi
h
pi
h
pi
cultur
supernat
collect
h
pi
viral
rna
isol
quantifi
rtqpcr
shown
fig
infect
affect
serin
cystein
proteas
inhibitor
howev
furin
inhibitor
led
signific
decreas
viru
yield
administ
pi
suggest
furin
furinlik
enzym
play
import
role
zikv
replic
assembl
egress
know
flavivirus
cell
entri
sensit
ph
chang
therefor
use
two
compound
increas
intravesicular
ph
fig
check
ph
depend
zikv
entri
vero
cell
treat
baf
h
prior
infect
next
cell
infect
zikv
presenc
baf
day
rtqpcr
analysi
reveal
strong
inhibit
infect
fig
next
use
confoc
microscopi
test
whether
compound
inde
inhibit
viru
entri
cell
treat
either
inhibitor
h
incub
zikv
min
presenc
inhibitor
confoc
microscopi
reveal
viral
particl
baf
cell
visibl
cytoplasm
probabl
trap
endosom
hub
unabl
undergo
fusion
fig
interestingli
observ
differ
intracellular
viru
distribut
cell
treat
small
number
zikv
virion
visibl
cytoplasm
zikv
particl
local
mainli
cell
surfac
baf
thought
prevent
endosom
acidif
therebi
prevent
viral
fusion
protein
activ
therefor
track
viral
capsid
envelop
protein
separ
visual
fate
cell
entri
examin
coloc
two
viral
compon
marker
differ
part
endosom
hub
baf
cell
min
pi
addit
file
figur
addit
file
figur
describ
nontreat
cell
zikv
capsid
envelop
protein
travel
togeth
late
endosom
fusion
occur
capsid
protein
enter
cytoplasm
envelop
protein
slowli
retraff
cell
surfac
presenc
baf
fusion
block
compon
tend
coloc
structur
min
pi
fig
suggest
presenc
baf
viral
particl
fuse
membran
vesicl
rather
destin
undergo
degrad
lysosom
howev
transport
back
cell
surfac
via
slow
recycl
pathway
differ
confoc
imag
observ
cell
treat
case
viru
particl
observ
cytoplasm
contrast
baf
cell
number
intern
virion
similar
control
cell
fig
first
use
flow
cytometri
analysi
test
whether
affect
bind
zikv
cell
surfac
would
explain
phenomenon
shown
fig
signific
impact
zikv
adhes
cell
next
despit
low
number
intern
viral
particl
examin
coloc
cellular
marker
addit
file
figur
addit
file
figur
cell
capsid
envelop
protein
coloc
fig
suggest
intern
virion
follow
normal
entri
rout
moreov
slightli
increas
coloc
envelop
protein
capsid
protein
min
pi
fig
may
suggest
least
singl
viru
particl
fusion
actual
occur
observ
presenc
although
viru
may
enter
cell
number
intern
virus
small
inhibitor
affect
viruscel
interact
hypothes
observ
phenomenon
may
result
extens
anterograd
transport
observ
coloc
therefor
exclud
role
exosom
viru
traffick
data
shown
verifi
role
fast
recycl
endosom
use
differ
approach
difficult
visual
rapid
process
examin
subcellular
local
zikv
upon
treatment
vero
cell
express
marker
protein
guid
endosom
fast
recycl
track
transient
silenc
presenc
major
virion
local
cell
surfac
control
scrambl
sirnatransfect
cell
wherea
cell
transfect
sirna
retain
within
cell
trap
near
cell
surfac
h
pi
fig
observ
led
us
conclud
impair
zikv
infect
earli
stage
redirect
virion
back
cell
surfac
intracellular
traffick
import
viru
replic
earli
stage
also
viru
assembl
egress
data
regard
remodel
endosom
hub
led
us
hypothes
compound
may
also
interfer
late
stage
infect
confirm
vero
cell
infect
h
zikv
normal
condit
ie
absenc
phmodifi
agent
afterward
cell
rins
thrice
pb
incub
day
standard
medium
contain
baf
although
baf
affect
viral
yield
led
log
reduct
fig
highlight
differ
mode
action
two
agent
identifi
role
late
stage
infect
infect
virus
hijack
inward
transport
machineri
cell
virus
abl
fuse
cell
membran
initi
infect
almost
immedi
entri
other
need
ferri
long
distanc
eg
infect
neural
cell
studi
focus
event
occur
initi
interact
zikv
cellular
receptor
observ
flavivirus
zikv
differ
vitro
model
find
demonstr
zikv
enter
vero
cell
clathrindepend
endocytosi
coloc
viral
particl
clathrin
observ
min
pi
expect
cme
howev
synchron
viru
entri
ideal
due
fact
process
regul
temperatur
numer
coloc
rate
signific
moder
fig
pearson
coeffici
rang
mander
coeffici
ensur
observ
coloc
artifact
complementari
studi
includ
clathrin
silenc
fig
cmespecif
inhibitor
fig
carri
confirm
initi
observ
subsequ
clathrindepend
intern
viru
encapsul
within
endosom
prior
deliveri
precis
defin
locat
transport
microenviron
within
matur
endosom
chang
gradual
fall
ph
cellular
proteas
alter
vesicl
membran
content
fluctuat
redox
potenti
affect
cargo
virus
finetun
becom
activ
condit
maxim
chanc
product
infect
therefor
case
event
take
place
precis
defin
site
within
endosom
hub
track
singl
dengu
viru
particl
reveal
pass
earli
endosom
fuse
predominantli
vesicl
membran
matur
late
endosom
min
pi
observ
zikv
traffick
congruent
find
notic
separ
zikv
envelop
capsid
protein
traffick
rout
min
pi
two
viral
protein
seen
togeth
last
time
structur
result
also
consist
data
obtain
novel
novel
surrogatereceptor
approach
describ
rawl
et
al
later
zikv
envelop
appear
transport
back
cell
surfac
via
slow
recycl
endosom
latter
observ
strike
commonli
believ
endocytosi
virus
avoid
leav
evid
presenc
plasma
membran
delay
detect
immunosurveil
system
multipl
studi
flavivirus
show
acquir
fusion
compet
envelop
protein
need
prime
proteolyt
two
site
first
cleavag
occur
transport
transgolgi
network
tight
complex
prm
e
protein
surfac
newli
form
immatur
virion
undergo
low
phinduc
conform
chang
follow
cleavag
furin
furinlik
proteas
consequ
matur
infecti
virion
carri
dimer
e
protein
metast
conform
releas
cell
second
event
occur
endocytosi
permiss
cell
e
protein
expos
low
ph
undergo
rearrang
enter
fusioncompet
state
identifi
factor
activ
zikv
fusion
protein
use
two
class
proteas
inhibitor
inactiv
cystein
proteas
eg
cathepsin
serin
proteas
affect
infect
process
howev
furin
inhibitor
hamper
replic
cycl
especi
present
late
stage
observ
consist
common
belief
furin
essenti
matur
zikv
similarli
flavivirus
despit
fact
zikv
e
protein
structur
resolv
furinspecif
cleavag
site
zikv
sequenc
present
report
show
role
furin
zikv
replic
avail
fig
one
may
conclud
furin
furinlik
enzym
activ
progeni
virus
second
proteas
requir
entri
suscept
cell
report
member
flavivirida
famili
contrast
result
advoc
role
furin
viru
matur
may
due
artifact
link
low
specif
proteas
inhibitor
use
show
entri
zikv
depend
endosom
ph
endosom
acidif
prerequisit
fusion
want
map
entri
singl
virion
cell
use
two
agent
commonli
use
assess
viru
depend
acid
environ
watersolubl
salt
ammonia
diffus
endosom
act
proton
sink
therebi
inhibit
acidif
endosom
second
compound
baf
vacuolar
type
hatpas
inhibitor
bind
sector
subunit
c
atpas
complex
inhibit
h
transloc
therebi
block
endosom
acidif
even
though
outcom
treatment
similar
mechan
action
appear
differ
presenc
baf
zikv
particl
intern
traffick
late
endosom
compart
howev
due
alter
ph
vesicl
virion
abl
enter
fusogen
state
remain
trap
endosom
seem
progress
slowli
lysosom
partial
degrad
lesser
extent
slow
recycl
cell
surfac
probabl
respons
remov
degrad
product
whole
virion
share
fate
envelop
protein
contrast
presenc
major
virion
retain
cell
surfac
suggest
limit
viru
attachmententri
first
confirm
interact
affect
basic
compound
alter
observ
consequ
potenti
caus
phenomenon
includ
limit
intern
retraffick
cell
surfac
limit
number
virion
local
insid
cell
meant
could
obtain
credibl
result
coloc
assay
signific
increas
coloc
slow
recycl
endosom
marker
observ
cell
tri
inhibit
fast
recycl
machineri
transient
transfect
vero
cell
sirna
target
fast
recycl
endosom
marker
deplet
result
retent
virion
insid
cell
show
inhibit
result
rewir
endosom
hub
rather
simpl
increas
endosom
ph
summar
map
entri
rout
zikv
use
vero
cell
research
model
result
consist
data
zikv
entri
cell
type
includ
primari
cell
suggest
viru
use
univers
entri
mechan
first
viru
use
cme
enter
cell
travel
endosom
compart
reach
late
endosom
prior
fusion
subsequ
viral
envelop
tend
recycl
cell
surfac
essenti
progeni
virus
prime
furinlik
enzym
assembl
entri
seem
proteaseindepend
interestingli
note
believ
simpli
buffer
endosom
microenviron
fact
redirect
cargo
eject
extracellular
space
previou
studi
report
similar
exampl
viru
entri
pathway
redirect
show
extern
factor
may
affect
viru
entri
nonobvi
way
believ
result
present
herein
increas
understand
zikv
biolog
also
provid
novel
molecular
target
futur
therapi
